Es wird erwartet, dass der Proteinexpressionsmarkt im Jahr 2028 4.000,67 Millionen US-Dollar erreichen wird, verglichen mit 2.221,73 Millionen US-Dollar im Jahr 2021. Es wird geschätzt, dass der Markt von 2021 bis 2028 mit einer durchschnittlichen jährlichen Wachstumsrate von 8,8 % wächst.
Der Der Umfang des Marktes für Proteinexpression umfasst Produkttyp, Dienstleistungen, Anwendung, Endbenutzer und Region. Je nach Region ist der Markt für Proteinexpression in Nordamerika, Europa, den asiatisch-pazifischen Raum, den Nahen Osten und Afrika sowie Süd- und Mittelamerika unterteilt. Der Bericht bietet Einblicke und eine eingehende Analyse des Marktes für Proteinexpression, wobei der Schwerpunkt auf verschiedenen Parametern wie Markttrends, technologischen Fortschritten, Marktdynamik und Wettbewerbslandschaftsanalyse führender Marktteilnehmer auf der ganzen Welt liegt. Es umfasst auch eine Analyse der Auswirkungen von COVID-19 in den gesamten Regionen.
Lukrative Regionen für den Markt für Proteinexpression
Markteinblicke
Zunehmende Anwendungen der Proteinexpression
Proteinexpression, ein integrales Werkzeug in der biologischen Forschung wird als pharmazeutischer Produktionsmechanismus für biologische Therapeutika immer wichtiger. Die Kombination aus alten Technologien wie künstlichen Enzymen und neuen Expressionssystemen der nächsten Generation revitalisiert Proteinexpressionsprotokolle. Die Entwicklung der Gentechnik und des Klonens hat viele Möglichkeiten für die Expression und Isolierung heterologer Proteine für Forschungszwecke eröffnet. Erhebliche Fortschritte in der Technologie haben die Expression und Isolierung rekombinanter Proteine in großem Maßstab ermöglicht.
Die Nachfrage nach rekombinanten Proteinen für die Anwendung beim Menschen steigt von Tag zu Tag. Es besteht ein großer Bedarf an neuartigen und verbesserten Bioverarbeitungsstrategien, die kosteneffektiv und zeitsparend sind. Die kontinuierliche Verbesserung biopharmazeutischer Expressionssysteme hat zur Herstellung von Qualitätsprodukten geführt. Moderne molekularbiologische Techniken stehen an der Spitze der Produktion biopharmazeutischer Proteine unter Verwendung verschiedener prokaryontischer oder eukaryontischer Expressionssysteme. Verschiedene innovative Techniken wie Systembiologie, Metabolic Engineering und CRISPR/Cas-Systeme können für das Stamm-Engineering eingesetzt werden, um die Leistung von Bioprozessen zu verbessern und biologisch aktive und stabile Proteine zu erzeugen.
Die globale Belastung durch Denguefieber nimmt rapide zu nimmt zu und wird so lange anhalten, bis ein wirksamer Impfstoff dagegen entwickelt ist. Verschiedene Impfstoffkandidaten gegen Denguefieber befinden sich in der präklinischen und klinischen Entwicklungsphase und basieren auf unterschiedlichen Ansätzen. Bei einigen Impfstoffen handelt es sich um einen tetravalenten, attenuierten Lebendvirus, einen gereinigten inaktivierten Virus, eine Untereinheit rekombinanter Proteine, Plasmid-DNA und Virus-vektorisierte Dengue-Impfstoffe. Jüngste Fortschritte bei rekombinanten, auf Untereinheiten basierenden Dengue-Impfstoffkandidaten unter Verwendung verschiedener Ansätze, wie z. B. Fusion mit anderen immunogenen Epitopen, Verwendung eines neuen Adjuvans, Proteinexpression in verschiedenen Wirtssystemen, Designer-Impfstoff und VLP-Entwicklung, eröffnen neue Wege für die Entwicklung ein voll wirksamer Impfstoff gegen Dengue-Fieber.
Derzeit werden mehr als 65 Millionen bestätigte Fälle und über 1,5 Millionen Todesfälle gemeldet. Die COVID-19-Pandemie hat zu erheblichen gesundheitlichen, sozialen und globalen Wirtschaftskrisen geführt. Die Entwicklung eines Impfstoffs gegen COVID-19 ist eine wirksame Strategie zur Eindämmung des Ausbruchs. Es ist erforderlich, dass der Impfstoff mit hoher Geschwindigkeit hergestellt wird und leicht skalierbar ist. Um den Zeitrahmen für die Impfstoffproduktion zu verkürzen, müssen rekombinante Protein-, Virusvektor- oder Nukleinsäure-basierte (rekombinante Plasmid-DNA und mRNA) Impfstoffe in Betracht gezogen werden. Der Einsatz der Proteinexpression nimmt während der Impfstoffentwicklung aufgrund der Vorteile rekombinanter Proteine zu, was das Wachstum des Proteinexpressionsmarktes vorantreibt.
Produkttypbasierte Einblicke
Basierend auf dem Produkttyp ist der Proteinexpressionsmarkt in Instrumente, Reagenzien, Expressionsvektoren und kompetente Zellen unterteilt. Das Reagenziensegment hielt im Jahr 2021 den größten Marktanteil. Außerdem wird geschätzt, dass das Reagenziensegment im Prognosezeitraum die höchste CAGR von 9,5 % auf dem Markt verzeichnen wird.
Globaler Proteinexpressionsmarkt, nach Produkt Typ 2021 und 2028
Servicebasierte Einblicke
Basierend auf Dienstleistungen ist der Proteinexpressionsmarkt in Antikörperentwicklung und -produktion, Proteinexpression und -produktion, Hybridom-One-Stop-Services, Entwicklung stabiler Zelllinien, bioanalytische Assay-Dienstleistungen. Das Segment Antikörperentwicklung und -produktion hatte im Jahr 2021 den größten Marktanteil. Es wird jedoch geschätzt, dass dasselbe Segment im Prognosezeitraum die höchste CAGR von 9,7 % auf dem Markt verzeichnet.
Anwendungsbasierte ErkenntnisseBasierend auf Anwendung ist der Proteinexpressionsmarkt in Forschung, Therapie und Industrie unterteilt. Das therapeutische Segment hatte im Jahr 2021 den größten Marktanteil und es wird geschätzt, dass dasselbe Segment im Prognosezeitraum die höchste CAGR von 9,4 % auf dem Markt verzeichnen wird.
Endbenutzerbasierte Erkenntnisse
< p>Basierend auf dem Endbenutzer ist der Proteinexpressionsmarkt in Pharma- und Biotechnologieunternehmen, akademische Forschungsinstitute und Auftragsforschungsorganisationen unterteilt. Das Segment der Pharma- und Biotechnologieunternehmen hielt im Jahr 2021 den größten Marktanteil. Außerdem wird geschätzt, dass das Segment im Prognosezeitraum mit 5,6 % die höchste CAGR auf dem Markt verzeichnet.
Strategische Einblicke
Anorganische Strategien wie Partnerschaften sowie Fusionen und Übernahmen werden häufig von Unternehmen übernommen, um auf die sich ändernde Kundennachfrage einzugehen und ihren Markennamen weltweit zu behaupten. Marktteilnehmer, die auf dem Proteinexpressionsmarkt tätig sind, wenden auch organische Strategien wie Produkteinführung und -erweiterung an, um ihre Präsenz und ihr Produktportfolio weltweit zu erweitern und der wachsenden Nachfrage gerecht zu werden.
Nach Produkttyp
< ul>
Nach Diensten
< ul>
Nach Anwendung
- Forschung
- Therapeutisch
- Industriell
Nach Endbenutzer
- Pharma- und Biotechnologieunternehmen
- Auftragsforschungsorganisationen
- Akademische Forschungsinstitute
- Andere< /li>
Nach Geografie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien
- Spanien
- Restliches Europa
- Asien-Pazifik (APAC)
- China
- Indien
- Südkorea
- Japan
- Australien
- Rest von APAC
- Naher Osten & Afrika (MEA)
- Südafrika
- Saudi-Arabien
- VAE
- Rest von MEA
- Süd- und Mittelamerika (SCAM)
- Brasilien
- Argentinien
- Rest von SCAM
- Thermo Fisher Scientific, Inc.
- GenScript
- Merck KGaA
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- New England Biolabs.
- Promega Corporation
- Oxford Expression Technologies Ltd
Unternehmensprofile
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Protein expression is a process in which proteins are synthesized, modified and regulated. Protein expression involves laboratory techniques & procedures which aid in manufacture of proteins. The technique allows to produce and purify the desired protein, either inside or outside a cell. The proteins synthesized using protein expression technique can be used for industrial processes or to diagnose and to treat diseases. Protein expression provides substrates or enzymes required for further analysis
Driving factors such as an development in the arena of proteomics and biotechnology industry, rising incidences of chronic and autoimmune diseases, rise in the awareness among people regarding protein expression, increasing focus on research and development process, growing usage of protein expression technologies in industrial protein manufacturing organizations, and rise in adoption of protein-based drugs over non-protein-based drugs are the prime growth drivers of protein expression market. In addition, increase in adoption of protein expression in emerging economies such as China, India and others, will create new opportunities for protein expression market. However, higher cost of the research and development, and complex government approval processes are the key restraints for protein expression market.
The Protein Expression market is anticipated to grow around 8.8% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2021.
Asia Pacific is projected to be the fastest growing region in the global market.
The costs of the Protein Expression are much higher, and they may cost US$ 300–1500, or more, per type. The cost may also differ from product to product types.
The List of Companies - Protein Expression Market
- Thermo Fisher Scientific, Inc.
- GenScript
- Merck KGaA
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- New England Biolabs.
- Promega Corporation
- Oxford Expression Technologies Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)